Our innovative concept is the protein engineering of receptor ligands to generate signalling agonists that modulate the activity of immune cells.
We use our proprietary phage display platform with a built in selection for folding and stability.
Highly efficient structure guided protein library design. Optimised library construction methods.
First-hand documented expert knowledge of the mechanisms governing salutary successful versus pathological inflammation.
State-of-the-art in vitro and in vivo models of inflammation-dependent diseases.